| John Joseph Thomas, MD | |
|
2000 Foundation Way Ste 2200, Ste 102, Martinsburg, WV 25401-9030 | |
| (304) 596-6902 | |
| (304) 596-6902 |
| Full Name | John Joseph Thomas |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 2000 Foundation Way Ste 2200, Martinsburg, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790888790 | NPI | - | NPPES |
| 1811350000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 21505 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Medical Center | Ranson, WV | Hospital |
| Berkeley Medical Center | Martinsburg, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
The problem is stark: One billion people on earth don't have enough food right now. It's estimated that by 2050 there will be more than nine billion people living on the planet. Meanwhile, current agricultural practices are amongst the biggest threats to the global environment. This means that if we don't develop more sustainable practices, the planet will become even less able to feed its growing population than it is today.
› Verified 5 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
The problem is stark: One billion people on earth don't have enough food right now. It's estimated that by 2050 there will be more than nine billion people living on the planet. Meanwhile, current agricultural practices are amongst the biggest threats to the global environment. This means that if we don't develop more sustainable practices, the planet will become even less able to feed its growing population than it is today.
› Verified 5 days ago
| Entity Name | Point Pleasant Physician Billing Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
The problem is stark: One billion people on earth don't have enough food right now. It's estimated that by 2050 there will be more than nine billion people living on the planet. Meanwhile, current agricultural practices are amongst the biggest threats to the global environment. This means that if we don't develop more sustainable practices, the planet will become even less able to feed its growing population than it is today.
› Verified 5 days ago
| Entity Name | University Healthcare Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659625739 PECOS PAC ID: 8325291404 Enrollment ID: O20130124000127 |
News Archive
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
The problem is stark: One billion people on earth don't have enough food right now. It's estimated that by 2050 there will be more than nine billion people living on the planet. Meanwhile, current agricultural practices are amongst the biggest threats to the global environment. This means that if we don't develop more sustainable practices, the planet will become even less able to feed its growing population than it is today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Joseph Thomas, MD 2500 Foundation Way, Martinsburg, WV 25401-9000 Ph: (304) 264-9202 | John Joseph Thomas, MD 2000 Foundation Way Ste 2200, Ste 102, Martinsburg, WV 25401-9030 Ph: (304) 596-6902 |
News Archive
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
The problem is stark: One billion people on earth don't have enough food right now. It's estimated that by 2050 there will be more than nine billion people living on the planet. Meanwhile, current agricultural practices are amongst the biggest threats to the global environment. This means that if we don't develop more sustainable practices, the planet will become even less able to feed its growing population than it is today.
› Verified 5 days ago
Robert Salade Strauch, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 Professional Court, Suite A, Martinsburg, WV 25401 Phone: 304-267-6119 Fax: 304-264-9105 | |
Omar Nadra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Foundation Way Ste 3100, Martinsburg, WV 25401 Phone: 304-350-3273 | |
Jason Turner, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Foundation Way Ste 2200, Martinsburg, WV 25401 Phone: 304-596-6900 Fax: 304-596-6902 | |
Dr. James Carrier, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Campus Dr Ste 221, Martinsburg, WV 25404 Phone: 681-247-1280 Fax: 681-247-1281 | |
Christopher Kelly Vincent, M.D. PH.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 Butler Ave, Department Of Surgery, Martinsburg, WV 25405 Phone: 304-263-0811 | |
Mr. John A Burgess V, Surgery Medicare: Accepting Medicare Assignments Practice Location: 215 S Louisiana Ave, Martinsburg, WV 25401 Phone: 304-263-3335 Fax: 304-267-5557 | |
Dr. Thomas A Baldwin, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 510 Butler Ave, Surgical Service, Martinsburg, WV 25401 Phone: 304-263-0811 |